See What HealthDay Can Do For You
Contact Us

Benefits for Women With Women-Only Cardiac Rehab

Improvements in women's health behaviors and psychosocial well-being versus mixed-sex rehab

woman gets physical exam

WEDNESDAY, Feb. 3, 2016 (HealthDay News) -- Women-only cardiac rehabilitation (CR) programs may confer behavioral and psychosocial advantages for women, according to a study published online Feb. 2 in the Canadian Journal of Cardiology.

Liz Midence, from York University in Toronto, and colleagues examined whether participation in women-only CR results in better outcomes than other models. Low-risk cardiac patients were recruited and surveyed regarding their health behaviors and psychosocial well-being. One hundred sixty-nine eligible participants were randomly allocated to mixed-sex, women-only, or home-based CR; 116 patients were retained.

The researchers found that women in mixed-sex and women-only CR groups had increased self-reported physical activity (per protocol and as treated, P < 0.05), and improvement in quality of life (per protocol and as treated, P < 0.05). Women in the women-only CR group had improvement in diet (as treated, P < 0.05). Compared with women in the women-only CR group, women in the mixed-sex CR group had higher anxiety symptoms (per protocol, P = 0.017) and higher depressive symptoms (as treated, P = 0.001). After adjustment for confounding variables there were no significant differences in any outcome by model.

"Behavioral and psychosocial outcomes were largely equivalent regardless of model; however, women-only programs may confer an advantage for anxiety and depressive symptoms," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.